CD8A and lung adenocarcinoma: Compared to normal samples, early-stage lung adenocarcinoma samples exhibit a significant increase in the number of CD8+ T cells, while late-stage lung adenocarcinoma samples show a notable decrease in CD8+ T cell numbers (Fig. 1G-H).